CD79A and Alzheimer disease: The increase in plasma IgA levels in AD patients fits well with previous studies demonstrating higher blood IgA levels in AD patients [16–18] or patients with cognitive dysfunctions [15], but contradicts other studies showing unaltered [19, 20] or decreased [21] blood IgA levels in AD patients.